The smart way to explore allergy. ALEX is the next generation in vitro test for type I allergies. A novel multi-parameter allergy test that is cost-efficient and delivers instantly correct results.
The smart way to explore allergy. ALEX, developed by MacroArray Diagnostics (MADx), is the next generation in vitro test for type I allergies. A novel multi-parameter allergy test that is cost-efficient and delivers instantly correct results.
How we reached the goals
Current technologies for discovering allergies are costly and unreliable. Medical practitioners must pre-select very few allergens for in-vitro testing, based on prior anamnesis, which often results in false or incomplete diagnosis. ALEXTM – Allergy Explorer test delivers right-first-time results for all allergic patients, while reducing the overall costs for the healthcare provider.
Spinverse helped plan an SME Phase 2 application and helped the client to present the right level of technical details. Together we formulated the way to present the business case and work plan for the project. We also provided assistance in the Grant Agreement preparation.
ALEXTM is the next generation in vitro test for type I allergy diagnostics. With an allergen panel of more than 280 allergens complemented by a total IgE measurement we aim at above 99% coverage of all routine diagnostic needs. It would also offer the most competitive price-value relation on the market.
With the help of Spinverse, MADx was able to secure a 2.5 M€ Horizon 2020 funding for their two-year project on developing their technology, disrupting the market of allergy testing
“With the help of Spinverse experts, we analyzed our existing business plan, expanded it with the right answers to new questions, and also created an easy to understand written plan. When you are very close to your own business it is very beneficial to receive input from fresh minds on how to best present your vision.
Spinverse took us step by step through the complex registration and application process of the SME instrument, which finally allowed us to receive a 2.5 Mio Euro funding for our project. Without the extensive know how and multi-disciplined team of Spinverse I doubt that we would have achieved this in the short timeframe we had in mind.”
– Christian Harwanegg, CEO, MacroArrayDiagnostics
Read more in MADx website